Malignant Pleural Effusions (Mpe)- Pleurodesis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Pleural Effusions (Mpe)- Pleurodesis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Pleural Effusions (Mpe)- Pleurodesis trials you may qualify forThe goal of this clinical research study is to learn if draining the IPC every day is better at than draining it 3 times a week.
This study aims to prospectively and multi-centrally explore the efficacy and safety of furmonertinib combined with upfront thoracic radiotherapy in treating NS…
Comparing Two Methods to Treat Fluid Build-up in Chest for Cancer Patients:Talc Powder Surgery versus Chest Tube Medicine.
Approximately half of all patients with metastatic cancer develop a malignant pleural effusion which is likely to lead to a significant reduction in quality of…
Malignant Pleural Effusion (MPE) is considered to be a common presentation at malignant tumors representing 15% of all cancer cases. It carries a burden on our…
The goal of this clinical research study is to compare indwelling pleural catheters (IPC) in combination with saline (the current standard of care) versus IPC i…
The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you…